PE20061137A1 - Compuestos derivados de macrolidos amino sustituidas - Google Patents

Compuestos derivados de macrolidos amino sustituidas

Info

Publication number
PE20061137A1
PE20061137A1 PE2005001311A PE2005001311A PE20061137A1 PE 20061137 A1 PE20061137 A1 PE 20061137A1 PE 2005001311 A PE2005001311 A PE 2005001311A PE 2005001311 A PE2005001311 A PE 2005001311A PE 20061137 A1 PE20061137 A1 PE 20061137A1
Authority
PE
Peru
Prior art keywords
morocco
quinolinyl
dihydro
oxo
carboxy
Prior art date
Application number
PE2005001311A
Other languages
English (en)
Spanish (es)
Inventor
Desmond John Best
Andrew Keith Forrest
Andrea Fajdetic
Robert John Sheppard
John Stephen Elder
Original Assignee
Glaxo Group Ltd
Pliva Istrazivacki Inst D O O
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxo Group Ltd, Pliva Istrazivacki Inst D O O filed Critical Glaxo Group Ltd
Publication of PE20061137A1 publication Critical patent/PE20061137A1/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H17/00Compounds containing heterocyclic radicals directly attached to hetero atoms of saccharide radicals
    • C07H17/04Heterocyclic radicals containing only oxygen as ring hetero atoms
    • C07H17/08Hetero rings containing eight or more ring members, e.g. erythromycins
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7042Compounds having saccharide radicals and heterocyclic rings
    • A61K31/7048Compounds having saccharide radicals and heterocyclic rings having oxygen as a ring hetero atom, e.g. leucoglucosan, hesperidin, erythromycin, nystatin, digitoxin or digoxin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10Antimycotics
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D405/00Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04Ortho-condensed systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Oncology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
PE2005001311A 2004-11-11 2005-11-09 Compuestos derivados de macrolidos amino sustituidas PE20061137A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0424959A GB0424959D0 (en) 2004-11-11 2004-11-11 Novel compounds

Publications (1)

Publication Number Publication Date
PE20061137A1 true PE20061137A1 (es) 2006-12-13

Family

ID=33523587

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2005001311A PE20061137A1 (es) 2004-11-11 2005-11-09 Compuestos derivados de macrolidos amino sustituidas

Country Status (19)

Country Link
US (2) US7718621B2 (enExample)
EP (1) EP1824870A1 (enExample)
JP (1) JP2008519788A (enExample)
KR (1) KR20070085919A (enExample)
CN (1) CN101098881A (enExample)
AR (1) AR053311A1 (enExample)
AU (1) AU2005303961A1 (enExample)
BR (1) BRPI0517792A (enExample)
CA (1) CA2587413A1 (enExample)
GB (1) GB0424959D0 (enExample)
IL (1) IL182978A0 (enExample)
MA (1) MA29213B1 (enExample)
MX (1) MX2007005776A (enExample)
NO (1) NO20072939L (enExample)
PE (1) PE20061137A1 (enExample)
RU (1) RU2007121581A (enExample)
TW (1) TW200630378A (enExample)
WO (1) WO2006050942A1 (enExample)
ZA (1) ZA200703603B (enExample)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7601695B2 (en) 2003-03-10 2009-10-13 Optimer Pharmaceuticals, Inc. Antibacterial agents
WO2007054295A1 (en) * 2005-11-09 2007-05-18 Glaxo Group Limited New 4*-substituted erythromycin derivative
JP2008540504A (ja) * 2005-05-10 2008-11-20 グラクソスミスクライン・イストラジヴァッキ・センタル・ザグレブ・ドルズバ・ゼー・オメイェノ・オドゴヴォルノスティオ 細菌感染症の処置に有用な4’’アミノ結合マクロライド
EP1945652A1 (en) * 2005-11-09 2008-07-23 Glaxo Group Limited Macrolones
AU2008298545B2 (en) 2007-09-14 2013-12-12 Vertex Pharmaceuticals Incorporated Modulators of cystic fibrosis transmembrane conductance regulator
EP2214484A4 (en) 2007-10-25 2013-01-02 Cempra Pharmaceuticals Inc PROCESS FOR PREPARING ANTIBACTERIAL MAKROLIDE AGENTS
TW200946109A (en) * 2008-05-09 2009-11-16 Enanta Pharm Inc Anti-bacterial activity of 9-hydroxy derivatives 6, 11-bicyclolides
CN102245195B (zh) 2008-10-24 2016-01-13 森普拉制药公司 使用含三唑的大环内酯的生物防御
US9937194B1 (en) 2009-06-12 2018-04-10 Cempra Pharmaceuticals, Inc. Compounds and methods for treating inflammatory diseases
JP5914335B2 (ja) 2009-09-10 2016-05-11 センプラ ファーマシューティカルズ,インコーポレイテッド マラリア、結核、及びmac病の治療方法
CA2799937A1 (en) * 2010-05-20 2011-11-24 Cempra Pharmaceuticals, Inc. Processes for preparing macrolides and ketolides and intermediates therefor
WO2012034058A1 (en) 2010-09-10 2012-03-15 Cempra Pharmaceuticals, Inc. Hydrogen bond forming fluoro ketolides for treating diseases
CA2868262A1 (en) 2012-03-27 2013-10-03 Cempra Pharmaceuticals, Inc. Parenteral formulations for administering macrolide antibiotics
HK1217665A1 (zh) 2013-03-14 2017-01-20 森普拉制药公司 用於治療呼吸道疾病的方法及其製劑
HK1218864A1 (zh) 2013-03-15 2017-03-17 森普拉制药公司 用於制备大环内酯抗菌剂的收敛方法
CN106589023A (zh) * 2016-11-22 2017-04-26 宜昌东阳光药业股份有限公司 一种罗红霉素杂质及其合成方法
WO2018178041A1 (en) 2017-03-30 2018-10-04 F. Hoffmann-La Roche Ag Novel pyrido[2,3-b]indole compounds for the treatment and prophylaxis of bacterial infection

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2808070A1 (de) * 1978-02-24 1979-08-30 Bayer Ag Verfahren zur herstellung von 4-pyridon-3-carbonsaeuren und/oder deren derivaten
GB0127349D0 (en) 2001-11-14 2002-01-02 Glaxo Group Ltd Macrolides
GB0225384D0 (en) * 2002-10-31 2002-12-11 Glaxo Group Ltd Novel compounds

Also Published As

Publication number Publication date
US20080269146A1 (en) 2008-10-30
CA2587413A1 (en) 2006-05-18
KR20070085919A (ko) 2007-08-27
MA29213B1 (fr) 2008-02-01
ZA200703603B (en) 2008-07-30
AR053311A1 (es) 2007-05-02
RU2007121581A (ru) 2008-12-20
NO20072939L (no) 2007-08-08
GB0424959D0 (en) 2004-12-15
EP1824870A1 (en) 2007-08-29
CN101098881A (zh) 2008-01-02
BRPI0517792A (pt) 2008-10-21
MX2007005776A (es) 2007-07-16
WO2006050942A1 (en) 2006-05-18
US20080090773A1 (en) 2008-04-17
TW200630378A (en) 2006-09-01
AU2005303961A1 (en) 2006-05-18
JP2008519788A (ja) 2008-06-12
IL182978A0 (en) 2007-08-19
US7718621B2 (en) 2010-05-18

Similar Documents

Publication Publication Date Title
PE20061137A1 (es) Compuestos derivados de macrolidos amino sustituidas
US8524738B2 (en) Quinolinones and quinoxalinones as antibacterial composition
NZ623574A (en) Ketolide compounds
AR027117A1 (es) Trifluorometilpirrolcarboxamidas y trifluorometilpirroltioamidas como fungicidas
GB0011944D0 (en) Organic compounds
JP2010511667A5 (enExample)
NZ594675A (en) Actagardine derivatives
PH12014502690A1 (en) Fungicidal composition and method for controlling plant diseases
TW200745034A (en) New compounds
PE20140649A1 (es) Derivado de macrolido sustituido en la posicion c4
MX2011012614A (es) Compuestos de quetolida que tienen actividad antimicrobiana.
UA101305C2 (ru) Антибактериальные производные хинолина
MX2007005709A (es) Compuestos de n-sulfonilaminobencil-2-fenoxiacetamida sustituidos.
MX2010002932A (es) Macrolidos de biarilo con puente en 6, 11.
PE20050582A1 (es) Derivados de quinolona como agentes antibacterianos
JO2725B1 (en) Quinoline antibacterial derivatives
HRP20100384T1 (hr) Antibakterijski derivati kvinolina
MX2009009074A (es) Macrolidos basados en eritromicina.
JO2970B1 (en) Quinoline antibacterial derivatives
JP2010511670A5 (enExample)
WO2002081437A3 (en) Novel n-p-propargyloxyphenethyl-thioacetic acid amides
UA101307C2 (ru) Антибактериальные производные хинолина
Foroumadi et al. Synthesis and in‐vitro antibacterial activity of new N‐substituted piperazinyl quinolones
RU2012131247A (ru) Экстракты kibdelos porangium в качестве антибактериальных средств
WO2008032204A8 (en) Substituted pyridylmethyl bicyclocarboxyamide compounds

Legal Events

Date Code Title Description
FC Refusal